TABLE 9.

Fatty acid compositions of the NEFAs in the plasma from the healthy subjects and COVID-19 patients.

Fatty acid (%)	Healthy subjects	COVID-19 patients	p
C16:0	34.20 ± 0.85	33.60 ± 0.86	NS
C16:1	4.63 ± 0.94	2.58 ± 0.29	0.04
C18:0	14.55 ± 0.47	12.07 ± 0.57	0.005
C18:1n-9	21.11 ± 1.20	25.20 ± 0.94	0.002
C18:2n-6	15.61 ± 0.52	17.92 ± 0.82	0.02
γ-C18:3n-6	0.87 ± 0.16	0.73 ± 0.12	NS
α-C18:3n-6	0.93 ± 0.22	0.79 ± 0.15	NS
C20:3n-6	6.01 ± 0.75	3.82 ± 0.36	0.003
C20:4n-6	1.54 ± 0.11	1.43 ± 0.17	NS
C20:5n-3	0.41 ± 0.11	0.07 ± 0.02	0.001
C22:6n-3	0.09 ± 0.046	0.02 ± 0.01	0.04

Data represent the weights of each individual FA/weights of total FAs as percentages (mean ± SE) Fatty acid nomenclature: C16:0, palmitic acid; C16:1n-7, palmitoleic acid; C18:0, stearic acid; C18:1n-9, oleic acid; C18:2n-6, linoleic acid; γ-C18:3n-6, γ-linolenic acid; α-C18:3n-3, α-linolenic acid; C20:3n-6, dihomo-γ-linolenic acid; C20:4n-6, arachidonic acid; C20:5n-3 eicosapentaenoic acid; C22:6n-3, docosahexaenoic acid. The bold values indicate significant changes.